Cinclus Pharma Overview
- Year Founded
-
2014

- Status
-
Public
- Employees
-
12

- Stock Symbol
-
CINPHA

- Share Price
-
$1.57
- (As of Friday Closing)
Cinclus Pharma General Information
Description
Cinclus Pharma Holding AB is a clinical stage pharmaceutical company developing a drug for the treatment of erosive gastroesophageal reflux diseases, and a dual therapy treatment with an antibiotic targeting Helicobacter pylori which is a bacteria that occurs in the gastric and duodenal mucosa. The Company's main target population is patients suffering from severe eGERD, where there is a lack of satisfactory treatment options.
Contact Information
Website
www.cincluspharma.comCorporate Office
- Kungsbron 1 Level 3
- Elevator G
- 111 22 Stockholm
- Sweden
Corporate Office
- Kungsbron 1 Level 3
- Elevator G
- 111 22 Stockholm
- Sweden
Cinclus Pharma Stock Performance
As of 14-Feb-2025, Cinclus Pharma’s stock price is $1.57. Its current market cap is $73.2M with 46.5M shares.
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$1.57 | $1.56 | $1.54 - $3.83 | $73.2M | 46.5M | 83.3K | -$0.42 |
Cinclus Pharma Financials Summary
As of 30-Sep-2024, Cinclus Pharma has a trailing 12-month revenue of null.
In Thousands, USD |
TTM 30-Sep-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
---|---|---|---|---|
EV | 64,968 | |||
Revenue | 0 | 561 | 1,042 | 0 |
EBITDA | (15,207) | (19,658) | (22,770) | (8,870) |
Net Income | (14,972) | (20,239) | (24,552) | (8,881) |
Total Assets | 65,194 | 9,447 | 17,808 | 16,263 |
Total Debt | 44 | 13,044 | 52 | 161 |
Cinclus Pharma Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Cinclus Pharma Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
---|
Cinclus Pharma Patents
Cinclus Pharma Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20230257378-A1 | Polymorphs of the hydrochloride salt of linaprazan glurate | Active | 05-Nov-2021 | ||
US-11820772-B2 | Polymorphs of the hydrochloride salt of linaprazan glurate | Active | 05-Nov-2021 | ||
US-20240067644-A1 | Polymorphs of the hydrochloride salt of linaprazan glurate | Pending | 05-Nov-2021 | ||
US-20220002297-A1 | Polymorphs of x842 | Inactive | 02-Jul-2020 | ||
AU-2020377451-A1 | Oral formulation of x842 | Pending | 04-Nov-2019 | A61K31/437 |
Cinclus Pharma Signals
Cinclus Pharma Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Cinclus Pharma ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile

Pharmaceuticals
Industry
Rank
Percentile

Biotechnology
Subindustry
Rank
Percentile

Cinclus Pharma FAQs
-
When was Cinclus Pharma founded?
Cinclus Pharma was founded in 2014.
-
Where is Cinclus Pharma headquartered?
Cinclus Pharma is headquartered in Stockholm, Sweden.
-
What is the size of Cinclus Pharma?
Cinclus Pharma has 12 total employees.
-
What industry is Cinclus Pharma in?
Cinclus Pharma’s primary industry is Drug Discovery.
-
Is Cinclus Pharma a private or public company?
Cinclus Pharma is a Public company.
-
What is Cinclus Pharma’s stock symbol?
The ticker symbol for Cinclus Pharma is CINPHA.
-
What is the current stock price of Cinclus Pharma?
As of 14-Feb-2025 the stock price of Cinclus Pharma is $1.57.
-
What is the current market cap of Cinclus Pharma?
The current market capitalization of Cinclus Pharma is $73.2M.
-
What is Cinclus Pharma’s annual earnings per share (EPS)?
Cinclus Pharma’s EPS for 12 months was -$0.42.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »